F-18-FDG PET/CT Can Predict Survival of Advanced Hepatocellular Carcinoma Patients: A Multicenter Retrospective Cohort Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Na, Sae Jung | - |
dc.contributor.author | Oh, Jin Kyoung | - |
dc.contributor.author | Hyun, Seung Hyup | - |
dc.contributor.author | Lee, Jeong Won | - |
dc.contributor.author | Hong, Il Ki | - |
dc.contributor.author | Song, Bong-Il | - |
dc.contributor.author | Kim, Tae-Sung | - |
dc.contributor.author | Eo, Jae Seon | - |
dc.contributor.author | Lee, Sung Won | - |
dc.contributor.author | Yoo, Ie Ryung | - |
dc.contributor.author | Chung, Yong An | - |
dc.contributor.author | Yun, Mijin | - |
dc.date.accessioned | 2021-09-03T07:01:39Z | - |
dc.date.available | 2021-09-03T07:01:39Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-05 | - |
dc.identifier.issn | 0161-5505 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/83705 | - |
dc.description.abstract | Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma (HCC) consists of a heterogeneous group of patients with a wide range of survival times, requiring further prognostic stratification to facilitate treatment allocation. We evaluated the prognostic value of F-18-FDG uptake on PET/CT at the time of presentation in patients with BCLC stage C HCC. Methods: A total of 291 patients with BCLC stage C HCC who underwent F-18-FDG PET/ CT between 2009 and 2010 for staging were retrospectively enrolled from 7 university hospitals. The patients were further divided into 2 groups according to the extent of disease, as intrahepatic or extrahepatic. Tumor-to-liver SUV ratio (TLR) of the primary tumor was measured on F-18-FDG PET/CT. Prognostic values of TLR and other clinical variables were analyzed to predict overall survival (OS) in univariate and multivariate analyses. Differences in the OS stratified by TLR were examined by the Kaplan Meier method. Results: Higher TLR was associated with extrahepatic disease (P = 0.018). On multivariate analysis, Child Pugh classification and TLR were independent prognostic factors in the intrahepatic disease group (all P < 0.05), whereas TLR was the only independent prognostic factor in the extrahepatic disease group (P < 0.05). Patients with high TLR showed a significantly worse OS than those with low TLR (P < 0.05) in both groups. Conclusion: In patients with BCLC stage C HCC, F-18-FDG uptake in the primary tumor was significantly higher in patients with extrahepatic disease than in those with intrahepatic disease. In addition, F-18-FDG uptake on pretreatment PET/CT had an incremental prognostic value for OS in both intrahepatic and extrahepatic disease groups. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SOC NUCLEAR MEDICINE INC | - |
dc.subject | POSITRON-EMISSION-TOMOGRAPHY | - |
dc.subject | EXTRAHEPATIC METASTASES | - |
dc.subject | LIVER-TRANSPLANTATION | - |
dc.subject | TUMOR RECURRENCE | - |
dc.subject | PROGNOSTIC VALUE | - |
dc.subject | 18F-FDG PET | - |
dc.subject | EXPRESSION | - |
dc.subject | FDG | - |
dc.title | F-18-FDG PET/CT Can Predict Survival of Advanced Hepatocellular Carcinoma Patients: A Multicenter Retrospective Cohort Study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Eo, Jae Seon | - |
dc.identifier.doi | 10.2967/jnumed.116.182022 | - |
dc.identifier.scopusid | 2-s2.0-85018965107 | - |
dc.identifier.wosid | 000400633500013 | - |
dc.identifier.bibliographicCitation | JOURNAL OF NUCLEAR MEDICINE, v.58, no.5, pp.730 - 736 | - |
dc.relation.isPartOf | JOURNAL OF NUCLEAR MEDICINE | - |
dc.citation.title | JOURNAL OF NUCLEAR MEDICINE | - |
dc.citation.volume | 58 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 730 | - |
dc.citation.endPage | 736 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | POSITRON-EMISSION-TOMOGRAPHY | - |
dc.subject.keywordPlus | EXTRAHEPATIC METASTASES | - |
dc.subject.keywordPlus | LIVER-TRANSPLANTATION | - |
dc.subject.keywordPlus | TUMOR RECURRENCE | - |
dc.subject.keywordPlus | PROGNOSTIC VALUE | - |
dc.subject.keywordPlus | 18F-FDG PET | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | FDG | - |
dc.subject.keywordAuthor | hepatocellular carcinoma | - |
dc.subject.keywordAuthor | F-18-FDG | - |
dc.subject.keywordAuthor | PET/CT | - |
dc.subject.keywordAuthor | survival | - |
dc.subject.keywordAuthor | prognosis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.